ATS 2022: Mortality Rate Reduced for COVID-19 Patients Treated With Imatinib Versus Placebo
Patients treated with imatinib also had shorter duration of invasive ventilation and shorter stays in ICU
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.